About 90 percent of new COVID-19 infections in Israel were caused by the CCP virus’s Delta variant, officials said, while adding that about half of the adults infected in the recent outbreak were fully vaccinated.
New cases of the virus rose to more than 200 on Thursday, from around 10 per day in most of June, officials said.
The health ministry reimposed the mask requirement for all indoor settings except the home, and said it was also recommending masks be worn at large outdoor gatherings, specifically mentioning gay pride events taking place around Israel this weekend.
Some 55 percent of Israel’s 9.3 million population have received both doses of the Pfizer vaccine, officials said. Eligibility was extended to 12- to 15-year-olds in May.
“Our goal at the moment, first and foremost, is to safeguard the citizens of Israel from the Delta variant that is running amok in the world,” Israeli Prime Minister Naftali Bennett said Wednesday, reported the WSJ.
The reimposition of the country’s mask mandate and potentially a new lockdown is sure to prompt questions about the general effectiveness of COVID-19 vaccines—and amid reports of so-called “breakthrough” cases in recent weeks.
“We’re learning that many of the breakthrough infections are asymptomatic or they’re very mild and brief in duration,” said Boston University infectious diseases specialist Davidson Hamer, the Boston Herald reported. “The viral load is not very high.”
“Breakthroughs are expected, and we need to better understand who’s at risk and whether people who have a breakthrough can transmit the virus to others,” Hamer said. “In some cases, they’ll be shedding such low levels of the virus and won’t be transmitting to others.”
And on April 30, the CDC reported that some 10,626 breakthrough cases were reported in 46 states and territories.
However, the U.N. agency warned that “changes or mutations in the virus should not make vaccines completely ineffective,” adding that if the “vaccines prove to be less effective against one or more variants, it will be possible to change the composition of the vaccines to protect against these variants.”
The Epoch Times has contacted Pfizer for comment.